Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 58Recruiting 17Terminated 12Unknown 8Active not recruiting 7Available 3Withdrawn 2Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 219Gastrointestinal 15Breast 13Gynecologic 8Thoracic 4Head & Neck 3Dermatologic 2CNS 2Sarcoma 1Plasma cell 1Other 1NET 1Endocrine 1

Conditions

Sarcoma 44Osteosarcoma 15Dendritic Cell Sarcoma, Interdigitating 12Rhabdomyosarcoma 9Bone Neoplasms 9Gastrointestinal Stromal Tumors 7Melanoma 5Sarcoma, Kaposi 4Sarcoma, Ewing 4Recurrence 4Neurofibrosarcoma 4Neoplasms 4Liposarcoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Alveolar Soft Part 3Breast Neoplasms 3Thyroid Neoplasms 2Sarcoma, Synovial 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neurofibromatosis 1 2Neuroblastoma 2Medulloblastoma 2Lung Neoplasms 2Leiomyosarcoma 2Leiomyoma 2Hodgkin Disease 2Histiocytoma, Malignant Fibrous 2Head and Neck Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × Sarcoma × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡